BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19109164)

  • 1. Btk regulates B cell receptor-mediated antigen processing and presentation by controlling actin cytoskeleton dynamics in B cells.
    Sharma S; Orlowski G; Song W
    J Immunol; 2009 Jan; 182(1):329-39. PubMed ID: 19109164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A balance of Bruton's tyrosine kinase and SHIP activation regulates B cell receptor cluster formation by controlling actin remodeling.
    Liu C; Miller H; Hui KL; Grooman B; Bolland S; Upadhyaya A; Song W
    J Immunol; 2011 Jul; 187(1):230-9. PubMed ID: 21622861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B.
    Mizuno T; Rothstein TL
    J Immunol; 2003 Mar; 170(6):2806-10. PubMed ID: 12626529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actin-binding protein 1 regulates B cell receptor-mediated antigen processing and presentation in response to B cell receptor activation.
    Onabajo OO; Seeley MK; Kale A; Qualmann B; Kessels M; Han J; Tan TH; Song W
    J Immunol; 2008 May; 180(10):6685-95. PubMed ID: 18453588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bruton's tyrosine kinase mediates NF-kappa B activation and B cell survival by B cell-activating factor receptor of the TNF-R family.
    Shinners NP; Carlesso G; Castro I; Hoek KL; Corn RA; Woodland RT; Scott ML; Wang D; Khan WN
    J Immunol; 2007 Sep; 179(6):3872-80. PubMed ID: 17785824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction.
    Fujimoto M; Poe JC; Satterthwaite AB; Wahl MI; Witte ON; Tedder TF
    J Immunol; 2002 Jun; 168(11):5465-76. PubMed ID: 12023340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
    Buhl AM; Cambier JC
    J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells.
    Glassford J; Soeiro I; Skarell SM; Banerji L; Holman M; Klaus GG; Kadowaki T; Koyasu S; Lam EW
    Oncogene; 2003 Apr; 22(15):2248-59. PubMed ID: 12700661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-wasp is essential for the negative regulation of B cell receptor signaling.
    Liu C; Bai X; Wu J; Sharma S; Upadhyaya A; Dahlberg CI; Westerberg LS; Snapper SB; Zhao X; Song W
    PLoS Biol; 2013 Nov; 11(11):e1001704. PubMed ID: 24223520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement.
    Petro JB; Rahman SM; Ballard DW; Khan WN
    J Exp Med; 2000 May; 191(10):1745-54. PubMed ID: 10811867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity.
    Middendorp S; Dingjan GM; Maas A; Dahlenborg K; Hendriks RW
    J Immunol; 2003 Dec; 171(11):5988-96. PubMed ID: 14634110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways.
    Satterthwaite AB; Lowell CA; Khan WN; Sideras P; Alt FW; Witte ON
    J Exp Med; 1998 Sep; 188(5):833-44. PubMed ID: 9730885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bruton's tyrosine kinase targets NF-kappaB to the bcl-x promoter via a mechanism involving phospholipase C-gamma2 following B cell antigen receptor engagement.
    Petro JB; Castro I; Lowe J; Khan WN
    FEBS Lett; 2002 Dec; 532(1-2):57-60. PubMed ID: 12459462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt.
    Craxton A; Jiang A; Kurosaki T; Clark EA
    J Biol Chem; 1999 Oct; 274(43):30644-50. PubMed ID: 10521450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Bruton's tyrosine kinase in the development and BCR/TLR-dependent activation of AM14 rheumatoid factor B cells.
    NĂ¼ndel K; Busto P; Debatis M; Marshak-Rothstein A
    J Leukoc Biol; 2013 Nov; 94(5):865-75. PubMed ID: 23804807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive signaling through CD72 induces mitogen-activated protein kinase activation and synergizes with B cell receptor signals to induce X-linked immunodeficiency B cell proliferation.
    Wu HJ; Venkataraman C; Estus S; Dong C; Davis RJ; Flavell RA; Bondada S
    J Immunol; 2001 Aug; 167(3):1263-73. PubMed ID: 11466342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice.
    Whyburn LR; Halcomb KE; Contreras CM; Lowell CA; Witte ON; Satterthwaite AB
    J Immunol; 2003 Aug; 171(4):1850-8. PubMed ID: 12902486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCR engagement induces Fas resistance in primary B cells in the absence of functional Bruton's tyrosine kinase.
    Tumang JR; Negm RS; Solt LA; Schneider TJ; Colarusso TP; Hastings WD; Woodland RT; Rothstein TL
    J Immunol; 2002 Mar; 168(6):2712-9. PubMed ID: 11884437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bruton's tyrosine kinase inhibition induces rewiring of proximal and distal B-cell receptor signaling in mice.
    Rip J; de Bruijn MJW; Neys SFH; Singh SP; Willar J; van Hulst JAC; Hendriks RW; Corneth OBJ
    Eur J Immunol; 2021 Sep; 51(9):2251-2265. PubMed ID: 34323286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of wiskott-aldrich syndrome protein in B-cell cytoplasmic tyrosine kinase pathway.
    Baba Y; Nonoyama S; Matsushita M; Yamadori T; Hashimoto S; Imai K; Arai S; Kunikata T; Kurimoto M; Kurosaki T; Ochs HD; Yata Ji; Kishimoto T; Tsukada S
    Blood; 1999 Mar; 93(6):2003-12. PubMed ID: 10068673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.